Clinical Trials Browser

Nasopharyngeal Carcinoma × famitinib × Head & Neck × Clear all

NCT01392235 2019-01-22

Famitinib in Treating Patients With Recurrent and/or Metastatic Nasopharyngeal Carcinoma (NPC)

Phase 2 Completed

Nasopharyngeal Carcinoma